ID   CEBe033-A-1
AC   CVCL_QX50
SY   GBA1_hESC_GBA#1-/-_10.18.11; GBA#1-/- hESC
DR   BioSamples; SAMEA104132790
DR   hPSCreg; CEBe033-A-1
DR   Wikidata; Q54809126
RX   PubMed=28925361;
CC   From: Hoffmann-La Roche Ltd; Basel; Switzerland.
CC   Knockout cell: Method=ZFN; HGNC; 4177; GBA1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=28925361
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 24,26
ST   Penta D: 9,13
ST   Penta E: 9,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B347 ! SA001
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
RX   PubMed=28925361; DOI=10.1016/j.scr.2017.07.009;
RA   Gundner A.L., Meyer C.A., Aigner S., Christensen K., Patsch C.,
RA   Jagasia R., Baumann K., Burcin M.;
RT   "Generation of a homozygous GBA deletion human embryonic stem cell
RT   line.";
RL   Stem Cell Res. 23:122-126(2017).
//